Press Release: Igyxos : Igyxos Initiates Phase 1 Clinical Trials for IGX12: A Breakthrough Treatment for Infertility

IGX12 is a pioneering monoclonal antibody (mAb) with very strong and consistent pre-clinical results and the potential to revolutionize infertility treatment PARIS, FRANCE, November 3, 2023 /⁨EINPresswire.com⁩/ -- Igyxos, a leading biopharmaceutical ...